Health Canada has approved a new antibody drug to help protect babies from serious illness caused by respiratory syncytial virus, or RSV.
Nirsevimab, also known by its brand name Beyfortus, was authorized on April 19. It was developed by AstraZeneca and Sanofi.
Monoclonal antibodies are made in a laboratory to mimic natural antibodies to prevent or treat diseases. “It’s a game-changer,” said Dr. Anna Banerji, a pediatric infectious disease specialist at the University of Toronto’s Dalla Lana School of Public Health.Many become seriously ill each year and have to be transported out of remote communities to hospitals in the south, she said.Although Health Canada has authorized nirsevimab for all infants, it’s not known whether it will be that widely administered.
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Health Canada approves new antibody drug to help prevent serious RSV in babiesHealth Canada has approved a new antibody drug to help protect babies from serious illness caused by respiratory syncytial virus, or RSV. Nirsevimab, also known by its brand name Beyfortus, was authorized on April 19. It was developed by AstraZeneca and Sanofi.
Read more »
Health Canada approves new antibody drug to help prevent serious RSV in babiesHealth Canada has approved a new antibody drug to help protect babies from serious illness caused by respiratory syncytial virus, or RSV.
Read more »
Health Canada approves new antibody drug to help prevent serious RSV in babiesHealth Canada has approved a new antibody drug to help protect babies from serious illness caused by respiratory syncytial virus, or RSV.
Read more »
Winnie Harlow's Cay Skin Launches in Canada | Elle CanadaAlmost a year after its launch, cayskin, the SPF-infused skincare line by winnieharlow is now available exclusively at Sephora Canada.
Read more »
‘It’s a game-changer’: New drug to protect babies from RSV approved - National | Globalnews.caHealth Canada has approved a new antibody drug to help protect babies from serious illness caused by respiratory syncytial virus, or RSV.
Read more »
First Nations ‘particularly and disproportionately’ overrepresented among B.C. toxic drug deaths - Terrace StandardFirst Nations ‘particularly and disproportionately’ overrepresented among B.C. toxic drug deaths
Read more »